Seven Bridges, one of the leading companies of ODTÜ TEKNOKENT in the field of biotechnology and that has its R&D center in ODTÜ TEKNOKENT, has managed to receive $50 million investment from Yıldırım Holding.

Seven Bridges, one of the leading companies of ODTÜ TEKNOKENT in the field of biotechnology and that has its R&D center in ODTÜ TEKNOKENT, has managed to receive $50 million investment from Yıldırım Holding.

The company was also listed by MIT as "one of the 50 most innovative companies in the world in 2016". Making $50 million invstment to Seven Bridges Genomics, a healthcare technology company founded by Deniz Kural, a graduate of Harvard University, Yıldırım Holding made the biggest investment of the year. Biomedical data analysis company Seven Bridges Genomics is accelerating the DNA research for cancer, drug development and sensitive drugs. Having previously received $48 million investment, the company has raised its total funding by $98 million.

* MIT Technology Review, 50 Smartest Companies in the World